PMGC Holdings Inc. 8-K

What Happened

• PMGC Holdings Inc. (ELAB) announced on April 16, 2026 that it entered a Securities Purchase Agreement giving it an equity line of credit of up to $40,000,000 through “Pre‑Paid Purchases.” The initial Pre‑Paid Purchase has an original principal of $10,730,000, with a $700,000 original issue discount (OID) and a $30,000 payment to the investor for transaction expenses. Investor also paid $1,000,000 for 262,467 registered shares. The company expects to receive approximately $9,727,380 in net proceeds from the initial closing (on or about April 17, 2026) after fees and expenses.
• PMGC’s operating subsidiaries (Northstrive Biosciences Inc.; PMGC Capital LLC; AGA Precision Systems LLC; Pacific Sun Packaging Inc.; and SVM Machining, Inc.) each signed guaranties, and the company granted the investor a first‑priority security interest in collateral (including subsidiary equity) under a Pledge Agreement.

Key Details

• Commitment: up to $40,000,000 in Pre‑Paid Purchases; Commitment Period runs from April 16, 2026 to the earlier of April 16, 2028, $40M funded, or termination.
• Initial economics: $10,730,000 principal; $700,000 OID; $30,000 transaction expense; investor paid $1,000,000 for Registered Shares; expected net proceeds ≈ $9,727,380.
• Ongoing terms: subsequent Pre‑Paid Purchases carry a 7.0% OID, accrue interest at 7.0% p.a., each request must be between $250,000 and the applicable maximum, and closings occur within three trading days of a request.
• Protections & limits: investor has a participation right to buy up to 10% of future financings; investor agreed not to sell, in any calendar week, more than 15% of the stock’s weekly dollar trading volume (absent an Event of Default); PMGC must reserve 7,500,000 shares for issuances under the agreement and seek shareholder approval for issuances that would exceed Nasdaq’s 19.99% cap.

Why It Matters

• This agreement gives PMGC quick access to up to $40M of capital via share issuances, providing liquidity flexibility without a single large equity offering. The company already closed an initial tranche that should deliver about $9.7M net cash.
• The facility is dilutive: future drawdowns convert to shares and the company must reserve shares and obtain shareholder approval for issuance above Nasdaq limits, which could increase outstanding shares. Investor protections (guaranties, a first‑priority pledge on subsidiary equity, and participation rights) strengthen the investor’s position relative to other holders.
• Investors should watch future draw requests, the number of shares issued as financings occur, any shareholder vote outcomes related to the Nasdaq 19.99% cap, and changes to subsidiary collateral that secure the investor’s interest.